EN
- Lactobacillus rhamnosus CCFM0528
- Lactobacillus crispatus CCFM1118
- Bifidobacterium longum CCFM760
- Bacillus coagulans-39
- 1) The antidiabetic effect of L. rhamnosus CCFM0528 on mice with type 2 diabetic induced by a high-fat diet and streptozotocin
- 2) Inhibits Helicobacter pylori and Supports Stomach Health
- 3) Balances Intestinal Flora and Improves Microecology
- 4) Relieves Constipation and Promotes Gut Motility
HelpGut® Kid Health - Promote Digestion
Formulation
Functionality
Scientific Support
Pre-clinical paper
1) (CCFM0528) Chen, P., Zhang, Q., Dang, H., Liu, X., Tian, F., Zhao, J., & Chen, W. (2014). Oral administration of Lactobacillus rhamnosus CCFM0528 improves glucose tolerance and cytokine secretion in high-fat-fed, streptozotocin-induced type 2 diabetic mice. Journal of Functional Foods, 10, 318-326.
2) (CCFM760) Zhang, Y., et al. (2025). Bifidobacterium longum CCFM760 combined with lactulose alleviates loperamide-induced constipation by regulating the gut microbiota and improving short-chain fatty acid metabolism. Food Science and Human Wellness.
3) (BC-39) Cao, J., Yu, Z., Liu, W., Zhao, J., Zhang, H., Zhai, Q., & Chen, W. (2024). MLST analysis of genetic diversity of Bacillus coagulans strains to evaluate effects on constipation model. Food Science and Human Wellness.
Patent
1) (CCFM1118) Jiangnan University, A strain of Lactobacillus crispatus capable of preventing and/or treating Helicobacter pylori infection. Granted Publication Number CN111548970B.
2) (CCFM0528) Jiangnan University, Lactobacillus rhamnosus CCFM0528 having diabetes preventing effect. Granted Publication Number CN103275905A.
3) (CCFM0528) Jiangnan University, Protective effects and application of a Lactobacillus rhamnosus on the alleviation of chronic alcoholic liver injury. Granted Publication Number US9649347B2.
4) (CCFM760) Jiangnan University, A strain of Bifidobacterium longum and its application (Promotes excretion and improves intestinal microecology).Granted Publication Number CN107893044B.